In a subset of BrafV637E-induced mSAs-HGD and carcinomas, however, we found partial CpG island methylation in the p16Ink4a (but not p19Arf) promoter (Figure S3), similar to observations in humans (Kriegl et al., 2011). The gene discussed is CDKN2A; the disease is carcinoma.